A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

Most people have the Epstein-Barr (EBV) virus. Sometimes people are unaware of this virus in their body; it settles into ...

Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a ...

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments ...

Over 95% of the world’s adult population is infected with Epstein–Barr virus (EBV), but most people never realise it. The ...

The Breakthrough Prize has announced its 2025 Laureates in Life Sciences, Fundamental Physics, and Mathematics. Among them are Professors Alberto Ascherio from Harvard University and Stephen Hauser ...

“Latent herpes viruses have the potential to reactivate in people living with HIV which can lead to neuroinflammation and impact long-term brain health,” said Shirin Mazumder, MD, infectious diseases ...

Multiple sclerosis is also caused by a virus carried by almost all humans. A new study provides an explanation as to why only certain people develop the disease. This also opens up the possibility of ...

Spironolactone, a drug used to manage salt absorption and fluid retention in heart failure patients, also plays a role in inhibiting function of a protein essential to Epstein-Barr virus, a member of ...

Multiple sclerosis is also caused by a virus carried by almost all humans. A new study provides an explanation as to why only certain people develop the disease. This also opens up the possibility of ...